This department is offering a grant to develop therapeutic interventions for fatal or disabling conditions identified through newborn screening or high-priority genetic disorders potentially screenable in the future. Projects demonstrating the benefits of early treatment for conditions not currently recommended for screening are encouraged. Closing date: May 07, 2021.
Opportunity ID: 301156
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-689 |
Funding Opportunity Title: | Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health Income Security and Social Services |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.350 — National Center for Advancing Translational Sciences |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Mar 01, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | May 07, 2021 |
Current Closing Date for Applications: | May 07, 2021 |
Archive Date: | Jun 12, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public and State controlled institutions of higher education County governments Small businesses City or township governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Private institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This FOA encourages research relevant to the development of therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as “high priority” genetic conditions where screening may be possible in the near future. Demonstrating the benefits of treatment is often a primary criterion for including a condition on a newborn screening panel; therefore, this FOA, a “high priority” condition is one where screening is not currently recommended but would significantly benefit from early identification and treatment. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-689.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00238721 | May 05, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259250 | May 05, 2018 | May 07, 2021 | View |
Package 1
Mandatory forms
301156 RR_SF424_2_0-2.0.pdf
301156 PHS398_CoverPageSupplement_4_0-4.0.pdf
301156 RR_OtherProjectInfo_1_4-1.4.pdf
301156 PerformanceSite_2_0-2.0.pdf
301156 RR_KeyPersonExpanded_2_0-2.0.pdf
301156 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
301156 RR_Budget_1_4-1.4.pdf
301156 RR_SubawardBudget30_1_4-1.4.pdf
301156 PHS398_ModularBudget_1_2-1.2.pdf
301156 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
301156 RR_SF424_2_0-2.0.pdf
301156 PHS398_CoverPageSupplement_5_0-5.0.pdf
301156 RR_OtherProjectInfo_1_4-1.4.pdf
301156 PerformanceSite_2_0-2.0.pdf
301156 RR_KeyPersonExpanded_2_0-2.0.pdf
301156 PHS398_ResearchPlan_4_0-4.0.pdf
301156 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
301156 RR_Budget_1_4-1.4.pdf
301156 RR_SubawardBudget30_1_4-1.4.pdf
301156 PHS398_ModularBudget_1_2-1.2.pdf
301156 PHS_AssignmentRequestForm_3_0-3.0.pdf